Form 4: Medtronic Director Andrea Jo Goldsmith Reports Stock Award and Tax Withholding
SEC Form 4 Filing
Andrea Jo Goldsmith, a director at Medtronic plc, reported the acquisition of shares through a restricted stock unit award and the subsequent withholding of shares for tax obligations.
Summary
- On April 28, 2025, Andrea Jo Goldsmith, a director of Medtronic plc, was awarded 2,083 ordinary shares at a price of $84.04 per share.
- These shares were granted as restricted stock units, vesting one year from the award date.
- Following this transaction, Goldsmith directly owns 10,463 ordinary shares, which includes 74 shares acquired through dividend reinvestment since the last report.
- On April 29, 2025, 216 shares were disposed of at $84.6 per share to cover tax obligations related to the vesting of restricted stock units.
- After this transaction, Goldsmith directly owns 10,247 ordinary shares.
- Goldsmith has granted power of attorney to several individuals to handle SEC filings on her behalf.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The filing reflects standard compensation practices and insider confidence, but doesn't contain any groundbreaking news.
Positives
- The acquisition of shares through restricted stock units indicates a long-term incentive and alignment of interests between the director and the company's performance.
Future Outlook
The restricted stock units vest one year from the award date, suggesting a future increase in ownership if vesting conditions are met.
Industry Context
Form 4 filings are routine disclosures for corporate insiders and provide transparency regarding their transactions in the company's stock. This filing indicates standard compensation practices through stock-based awards.
Comparison to Industry Standards
- Stock awards are a common component of executive compensation packages in the medical device industry, aligning management's interests with those of shareholders.
- Companies like Johnson & Johnson, Abbott Laboratories, and Stryker also utilize stock awards as part of their compensation strategy.
- The vesting period of one year is a typical timeframe for restricted stock units.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
- Employees may view the stock award as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 04/03/2025 | Date of Power of Attorney execution. |
| 04/28/2025 | Date of restricted stock units award. |
| 04/29/2025 | Date of shares withheld for tax payment. |
| 04/30/2025 | Date of signature for the report. |
Keywords
Form 4, Medtronic, Director, Goldsmith, Stock Award, Tax Withholding, Restricted Stock Units, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.